Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems.
Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.
Location: United States, Washington, Seattle
Member count: 11-50
Total raised: $46M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | iQFunds | inqbator.c... |
| - | Debiopharm | debiopharm... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 03.04.2015 | - | $40M | - | medcitynew... |
| 06.03.2014 | - | $6M | - | finsmes.co... |
Mentions in press and media 9
| Date | Title | Description | Category | Author | Source |
| 21.10.2022 | When Advan... | Rolland Carlson, CEO of Immune... | - | Rolland Ca... | hitconsult... |
| 30.11.2021 | Press rele... | PRESS RELEASE: 30 November 202... | - | - | marketscre... |
| 16.09.2021 | Immunexpre... | Immunexpress, Inc., a molecula... | - | - | aithority.... |
| 23.08.2021 | Immunexpre... | BRISBANE, Australia, Aug. 23... | - | - | prnewswire... |
| 03.06.2021 | Gut therap... | MicrobiomX’s device for stool ... | - | Charlotte ... | geekwire.c... |
| 03.10.2019 | Immunexpre... | Immunexpress, Inc., a Seattle,... | USA | - | finsmes.co... |
| 03.04.2015 | Immunexpre... | There’s a reason sepsis still ... | - | - | medcitynew... |
| 06.03.2014 | Immunexpre... | Immunexpress Group, a Brisbane... | Australia ... | - | finsmes.co... |
| - | Immunexpre... | Seattle diagnostics company Im... | - | - | medcitynew... |